Newly discovered genetic marker predicts breast cancer patients' treatment outcomes
A multidisciplinary team of researchers from Roswell Park Comprehensive Cancer Center and Kaiser Permanente Northern California have identified the first pharmacogenomic marker for anthracyclines and HER2-targeting drugs, ...
Mar 23, 2022
0
12